ETTX News and Press, Entasis Therapeutics Holdings Inc. From 10/19/21

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, trader! It’s time to get right back into investing with a look at the biggest pre-market stock movers for Tuesday! Source: f11photo/Shutterstock.com News moving shares in early morning trading t...

SUL-DUR first to achieve statistical non-inferiority in 28-day all-cause mortality in carbapenem-resistant Acinetobacter (CRAB) patients Statistically significant difference in clinical cure at Test of Cure vs. colistin Favorable safety profile with statistically significant...

WALTHAM, Mass., Sept. 23, 2021 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial products, announced today that management will participate in the upcoming Cantor ...

3 Tips For Investing in Penny Stocks in a Down Market When the stock market is down, it presents a sizable number of opportunities for penny stock investors to capitalize on. But, it takes understanding why the market is down to do so. With penny stocks , there are several differenc...

Gainers: Helbiz HLBZ +135%. Corvus Pharmaceuticals CRVS +77%. Innate Pharma IPHA +37%. Worksport (OTCQB:WKSP) +20%. Priority Technology Holdings (NASDAQ:PRTH) +15%. Entasis Therapeutics (NASDAQ:ETTX) +15%. Capital Senior Living Corporation (NYSE:CSU) +13%. Evelo (NASDAQ:EVLO) +...

WALTHAM, Mass., Sept. 15, 2021 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial products, today announced the publication of a profile of the company’s...

WALTHAM, Mass., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial products, announced today that management will participate in the upcoming H.C. Wa...

Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Mond...

Entasis Therapeutics Holdings Inc. (ETTX) Q2 2021 Earnings Conference Call August 12, 2021 8:00 a.m. ET Company Participants Bruce Mackle - Managing Director, LifeSci Advisors Manoussos Perros - President and CEO Mike Gutch - CFO and Chief Business Officer David Altarac - Chief Medical Office...

Entasis Therapeutics (NASDAQ:ETTX): Q2 GAAP EPS of -$0.29 beats by $0.03. As of June 30, 2021, cash and cash equivalents were $56.4 million, compared to $53.2 million as of December 31, 2020.  Press Release For further details see: Entasis Therapeutics EPS ...